Ligand validation:6WDU

KOU: (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-serine

KOU is a Ligand Of Interest in 6WDU designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6WDU_KOU_B_410	92%	9%	0.098	0.988	2.96	1.51	4	4	0	0	100%	1
7JMQ_KOU_B_406	95%	59%	0.083	0.987	0.82	0.74	1	-	0	0	100%	1
7K5A_KOU_B_403	92%	46%	0.091	0.983	0.95	1.15	2	4	0	0	100%	1
6XSY_KOU_B_415	89%	49%	0.099	0.977	1.08	0.91	2	1	0	0	100%	1
6DZO_KOU_B_408	87%	7%	0.101	0.974	3.43	1.36	5	4	0	0	100%	1
7JQW_KOU_B_415	85%	34%	0.108	0.972	1.57	1.07	4	2	0	0	100%	1
4IY7_KOU_B_403	96%	12%	0.078	0.985	2.34	1.72	5	6	11	0	100%	1
3PC4_KOU_A_702	93%	17%	0.077	0.971	2.38	1.3	4	3	3	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.